Trending
- The Drp1 inhibitor DRP1i2 confers cardioprotection against doxorubicin-induced cardiotoxicity
- Cuproptosis: an emerging member of the immunogenic cell death family
- Weighing Real-World Data Vs Clinical Trials for NALIRIFOX in PDAC
- Five-Year KEYNOTE-775 Data Confirm Durable Benefit With Lenvatinib Combo
- Strategic roadmap for delivery of clinical trials in rare childhood central nervous system (CNS) tumours: a multi-stakeholder consensus
- This yeast supplement may boost cancer-fighting immunity
- Epithelial interferon-stimulated gene programs modulate chemotherapy sensitivity in colorectal cancer via EPSTI1
- Serum metabolomics identifies phenylalanine and carnitine-associated vulnerabilities in colorectal cancer
Sunday, August 23